Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FHC Group is a prominent Portuguese pharmaceutical conglomerate that operates across the entire medicine value chain, including research and development, manufacturing, and global distribution. Founded in 1998, the group has expanded its presence to four continents and over 60 countries, providing a wide range of healthcare products and logistics solutions. Its core manufacturing arm, Laboratórios Basi, produces a diverse portfolio of medicines, while subsidiaries like Empifarma and Overpharma handle large-scale distribution in both outpatient and hospital markets. The company also offers specialized consulting services in regulatory affairs and health information technologies through its Phagecon and ePharma units.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on F&C Group.